Don't wait until it's too late: Burn care essentials every home needs
While many households are equipped with the basics like band-aids and antiseptic cream, burn-specific first aid items are often overlooked.
Yet, when it comes to burn injuries, immediate and proper care can make a significant difference in recovery, pain management, and preventing long-term scarring.
If you're still reaching for ice cubes or toothpaste (seriously, skip those), it's time to give your home first aid kit a much-needed upgrade.
Here's a checklist of essential burn care items that every household should have, but probably doesn't.
Hydrogel dressings
These cooling dressings are specifically designed for burns.
They not only relieve pain by reducing skin temperature but also keep the wound moist, which is crucial for healing.
Unlike ice, which can damage the skin further, hydrogel dressings provide immediate comfort and are safe to apply directly onto minor burns.
Sterile cling film (plastic wrap)
It may surprise you, but cling film is often recommended by medical professionals to loosely cover a burn after cooling it with water.
It helps protect the wound from infection without sticking to the skin. Always use a clean, non-perfumed variety, and only apply it once the burn has been rinsed thoroughly under cool running water for at least 20 minutes. Image for illustrative purposes only. - 123RF
Thermometer
Burn injuries can sometimes lead to infection, which may cause a fever.
A reliable thermometer helps you keep track of any unexpected temperature changes, especially in children. If fever or increased pain and swelling develops, it's time to see a doctor.
Non-adhesive sterile dressings
Burns can be extremely sensitive, and regular sticky plasters are not ideal.
Non-adhesive dressings are designed to protect wounds without sticking to them, which prevents further skin damage during dressing changes. They're a gentle yet effective option for covering healing burns.
Saline solution
Sterile saline is useful for flushing out burns, especially if debris or chemicals are involved.
While water is generally the go-to, having saline on hand can be helpful in situations where tap water isn't available or clean. Image for illustrative purposes only. - Photo via Pinterest, edited in Canva
Disposable gloves
Infection is a major risk for open wounds, and burns are particularly vulnerable.
Wearing disposable gloves while treating a burn helps maintain hygiene, especially if you're applying gels, changing dressings, or handling broken skin.
Tweezers (sterilised)
Useful for removing any debris gently from a minor burn or for handling small items like dressings and bandages without direct contact.
Just be sure they're clean and stored in a sealed container.
Pain relief medication (Paracetamol or Ibuprofen)
Even small burns can be surprisingly painful. Over-the-counter pain relievers help manage discomfort and reduce inflammation.
Always follow the dosage instructions and consult a pharmacist or doctor if unsure. Image for illustrative purposes only. - CANVA
Emergency contact list
In case of a serious burn, time is critical.
Keep a printed list of emergency numbers, including your nearest clinic, hospital, and poison control or medical hotline, especially if children are in the home.
Bonus tip: What NOT to use
While it might be tempting to reach for butter, toothpaste, or ice, these are outdated remedies that can make things worse.
Ice can damage the skin further, while household products may trap heat or introduce bacteria. Stick to cool running water and the items above.
Burn injuries can range from minor kitchen mishaps to more serious accidents, and having the right items on hand can be a literal lifesaver.
A well-stocked burn first aid kit ensures you're not scrambling in panic during an emergency.
So take this checklist, give your kit a quick audit, and stock up on what's missing. Because when it comes to burns, preparation is key, and healing starts within the first few minutes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
6 hours ago
- The Star
More protection against pneumonia with newly-approved vaccine
Young children are one of the high-risk groups for developing serious and potentially fatal pneumonia. — Canva Malaysians can now be protected against 20 strains of the bacteria Streptococcus pneumoniae , which is one of the main causes of pneumonia. This follows the recent announcement that the Health Ministry has approved the 20-valent pneumococcal conjugate vaccine (PCV20) by American pharmaceutical company Pfizer. This new vaccine offers protection against an additional seven serotypes of S. pneumoniae , also known as pneumococcus, compared to its 13-valent predecessor (PCV13). These include newer strains associated with antibiotic resistance and high death rates. Professor Dr Mark van der Linden, who heads the national reference centre for Streptococci in Germany, notes that scientists have been racing to keep up with the evolving strains of pneumococcus. 'There are currently 107 known serotypes. 'We're not creating new ones; they evolve naturally. 'Pneumococcus reproduces every 30 minutes, so it adapts far faster than humans,' he shares. The first conjugate vaccine, which was developed specifically for use in young children, targeted the seven serotypes that caused the majority of pneumococcal disease. This 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in Malaysia over two decades ago. As vaccination reduced these strains, others emerged – a process called serotype replacement. 'We saw a 40% drop in cases, but new strains emerged. 'That's why vaccines must continuously evolve. 'We can't cover all 107, but expanding coverage is essential, especially for high-risk groups,' says Prof van der Linden. ALSO READ: How vaccines are developed Meanwhile, consultant clinical microbiology and infection physician Dr Teresa Wang Kin Fong from Hong Kong explains that based on data from the Chinese territory, invasive pneumococcal disease is now more common among adults than children. 'We used to give adults the polysaccharide vaccine PPV23, but it had limited effectiveness. 'Pfizer later developed PCV7, and at one point, we [in Hong Kong] implemented a combined adult programme using both PPV23 and PCV7. 'Now with PCV20, we can skip PPV23 entirely. 'PCV20 offers broader protection and simplifies the process to a single dose, making it more convenient for patients and doctors alike.' In Malaysia, vaccine uptake among adults remains low. 'This is largely due to the outdated perception that vaccines are only for children,' notes Malaysian Society of Infectious Diseases and Chemotherapy past president Prof Dr Zamberi Sekawi. Adults with chronic conditions like diabetes, high blood pressure and lung disease, are especially vulnerable to developing severe pneumonia, which can be life-threatening. ALSO READ: Rebooting the adult immune system when it becomes less effective Vaccinating adults not only protects individuals, but also reduces transmission within households. 'When one family member brings home an infection, the whole household is at risk. 'Vaccinating adults helps break that chain,' Prof Zamberi adds. This is important as both young children and the elderly are also vulnerable to developing severe pneumonia. 'Children are born with immature immune systems. 'As we age, our immune system weakens – a process called immunosenescence. 'That's why both groups need the most protection,' says consultant paediatrician Prof Datuk Dr Zulkifli Ismail. Since the Covid-19 pandemic, parental concerns about vaccination have shifted from cultural or religious questions to fear of side effects. 'I've had parents who declined the pneumococcal vaccine, only to return later after their child was hospitalised. 'Sadly, by then it's too late,' shares Prof Zulkifli. ALSO READ: Addressing the concerns that trigger vaccine hesitancy PCV20 is approved for use in both children and adults starting from the age of six weeks onwards.
Sinar Daily
2 days ago
- Sinar Daily
Liver cancer to double worldwide, most of it preventable
It is also the third deadliest of all cancers, with the study predicting it would take 1.37 million lives by the middle of the century. 03 Aug 2025 09:00am Three out of five cases of liver cancer could be prevented, the international team of experts said. - 123RF photo for illustration purpose only Three out of five cases of liver cancer could be prevented, the international team of experts said. - Photo illustrated by Sinar Daily PARIS - The number of people with liver cancer will nearly double worldwide by 2050 unless more is done to address preventable causes such as obesity, alcohol consumption and hepatitis, a study warned. New cases of liver cancer -- the sixth most common form of the disease -- will rise to 1.52 million a year from 870,000 if current trends continue, according to data from the Global Cancer Observatory published in the Lancet medical journal. It is also the third deadliest of all cancers, with the study predicting it would take 1.37 million lives by the middle of the century. However three out of five cases of liver cancer could be prevented, the international team of experts said. The risk factors are drinking alcohol, viral hepatitis and a build-up of fat in the liver linked to obesity called MASLD, which was previously known as non-alcoholic fatty liver disease. The viruses that cause hepatitis B and C are expected to remain the leading causes of liver cancer in 2050, according to the study, published on World Hepatitis Day. Vaccination at birth is the best way to prevent hepatitis B, but vaccine coverage remains low in poorer countries including in sub-Saharan Africa, the study said. Unless vaccination rates are increased, hepatitis B is expected to kill 17 million people between 2015 and 2030, it added. Alcohol consumption is estimated to cause more than 21 percent of all cases of liver cancer by 2050, up more than two percentage points from 2022. Cancer due to obesity-linked fat in livers will rise to 11 percent, also up more than two percentage points, the researchers calculated. The large-scale study, which reviewed the available evidence on the subject, underscored "the urgent need for global action" on liver cancer, the authors said. The experts called for more public awareness about the preventable danger of liver cancer, particularly by warning people with obesity or diabetes about fatty-liver disease in the United States, Europe and Asia. - AFP More Like This
The Star
6 days ago
- The Star
Game-changing treatment for advanced prostate cancer
Prostate cancer is the third most common cancer among Malaysian men, with cases rising steadily since 2012. While it trails behind colorectal and lung cancer, it is still a significant concern. What's more worrying is that many cases are detected late. Early-stage prostate cancer is highly treatable, but late-stage cases are far more difficult to manage. What is prostate cancer? The disease begins when cells in the prostate – a small, walnut-sized gland below the bladder – start to grow uncontrollably. In its early stages, prostate cancer often causes no symptoms. But as the tumour grows, it can press against the urethra – the tube that carries urine – leading to changes in urination. Left untreated, the cancer can spread to nearby tissues, lymph nodes, or even the bones, making it more difficult to treat and manage. Yet, many men overlook the early signs. However, symptoms such as difficulty urinating, weak flow, or frequent trips to the bathroom at night may be early warning signs of prostate cancer. Sunway University consultant urologist and urologic oncologist Professor Dr Tan Guan Hee explains that these symptoms often go unnoticed or are mistaken for benign prostate conditions such as benign prostatic hyperplasia. 'Many men assume it's just part of getting older and delay seeing a doctor,' he says. 'Unfortunately, this means prostate cancer is often diagnosed at a later stage, when it's more difficult to treat.' As Malaysia's population continues to age, the number of prostate-related issues is expected to rise in tandem. Despite this, there is a general lack of awareness of the problem, minimal symptoms in early stages, and a cultural reluctance to seek help for intimate health issues. When prostate cancer is detected early, treatment options such as surgery or radiotherapy are often effective and potentially curative. However, late-stage prostate cancer, which may have already spread to bones or lymph nodes (metastasised), requires more advanced interventions. This is where radioligand therapy (RLT) offers new hope. Overcoming stigma One significant and often overlooked challenge in managing prostate cancer is cultural reluctance. Many patients delay seeking care due to embarrassment or denial, particularly Asian men, who may be more reserved about discussing health issues. Doctors often find that families bring in patients who have ignored symptoms for years. Prof Tan says: 'Addressing this cultural barrier requires greater public awareness, normalising conversations around men's health, and encouraging routine screening and early intervention.' Beyond individual awareness, family involvement plays a critical role in detecting early symptoms of prostate cancer and preventing critical outcomes. 'If children notice their father is frequently going to the toilet, they might realise something is amiss and encourage him to seek medical help,' he suggests. Treatment for prostate cancer depends on what stage the tumour is at. — Photos: Canva Precision treatment According to consultant clinical oncologist Dr Nik Muhd Aslan Abdullah, treatment for prostate cancer has come a long way since the 1990s. While surgery, radiotherapy and hormonal therapy remain standard options, recent advances in precision medicine have led to more targeted, effective treatments. Choosing the most appropriate treatment depends on several factors, including: > The stage of the cancer > The patient's age > Personal preferences > Underlying health conditions that may make certain treatments, such as surgery, unsuitable. 'In the past, our precision treatment options were quite limited. 'But today, we are guided by clearer staging and more accurate tools,' he says. Dr Nik outlines the four key stages that influence treatment strategy: > Stage 1: The tumour is confined to the prostate and involves no more than half of the gland. > Stage 2: The tumour remains within the prostate but is more advanced. > Stage 3: The tumour has grown beyond the prostate and may have reached nearby structures such as the seminal vesicles, rectum or bladder. > Stage 4: The cancer has spread to the lymph nodes or distant parts of the body, such as the bones. 'To determine the stage, we typically rely on three approaches: physical examination, blood tests, particularly for prostate-specific antigen (PSA), and imaging. 'Conventional imaging includes computed tomography (CT) scans, magnetic resonance imaging (MRI), and bone scans,' he explains. However, these methods have their limitations. Dr Nik adds: 'They may miss early tumours or small areas of spread, and while blood tests are helpful, they cannot show the precise location of the cancer.' Sharper detection with PSMA PET-CT A key development is PSMA PET-CT imaging – a powerful diagnostic tool that combines positron emission tomography (PET) with CT to detect prostate-specific membrane antigen (PSMA), a protein found on most prostate cancer cells. 'About 80% of prostate cancer cells have a protein called PSMA on their surface,' explains Sunway University consultant nuclear medicine physician Associate Prof Dr Tan Teik Hin. 'We use this to both detect and treat cancer. The approach is simple: we treat what we see, and we see what we treat.' PSMA PET-CT works like a GPS for cancer cells. The CT maps the body's structure, while the PET scan lights up areas where PSMA-positive cancer cells are present. It can detect tumours as small as 0.3cm, far smaller than what conventional scans typically reveal. In an April 2020 ProPSMA study published in The Lancet , researchers found that this method was 27% more accurate than traditional imaging, often leading to significant changes in treatment planning. What is radioligand therapy or RLT? Once PSMA-positive cancer cells are identified, patients may be eligible for RLT. This treatment uses a radioactive compound that binds specifically to PSMA on cancer cells, delivering a precise dose of radiation directly to the tumour while sparing surrounding healthy tissue. Assoc Prof Teik Hin says: 'It's like sending a guided missile to destroy only the cancer cells. 'RLT is not entirely new. A similar concept – using radioactive iodine to treat thyroid cancer – has been in use for over 80 years. 'What's new is applying the same principle to prostate cancer using more advanced, highly specific radiotracers.' After treatment, a follow-up scan (SPECT-CT, a hybrid imaging technique that combines Single Photon Emission Computed Tomography and CT) is conducted to confirm that the radioligand successfully reached and treated the target. From left: Assoc Prof Teik Hin, Prof Tan and Dr Nik were the three medical professionals who led the roundtable discussion on RLT. — Handout Fewer side effects One of the greatest advantages of RLT is its specificity. Because the therapy targets only cancerous cells, it causes fewer side effects compared to systemic treatments like chemotherapy or hormonal therapy. Most patients tolerate it well, with mild side effects such as dry mouth, fatigue or nausea. More importantly, studies show that RLT can help delay disease progression, reduce symptoms like pain, and improve quality of life, especially for men with advanced or castration-resistant prostate cancer. While RLT is currently used mainly for patients with stage 4 prostate cancer who no longer respond to other treatments, ongoing clinical trials are exploring its use at earlier stages. PSMA PET-CT is also being studied for its ability to guide biopsies and detect cancer even before a formal diagnosis is made. 'Compared to systemic hormone therapy, which affects the entire body and can cause fatigue and mood changes, RLT offers a more targeted approach with fewer disruptions to daily life. 'We see a marked improvement in quality of life, and patients report less pain, more energy, and better sleep after the therapy,' says Assoc Prof Teik Hin. The treatment is available at government facilities such as the National Cancer Institute (IKN) in Putrajaya and Hospital Kuala Lumpur, as well as at several private hospitals. The cost of RLT varies depending on the hospital, the number of treatment cycles, and individual response to the treatment. As there is no fixed price, patients are encouraged to consult their medical team to discuss affordability and explore available financial support options. The three experts were discussing 'Size Matters in Prostate Cancer: Experts Highlight Advances to Close Critical Gaps in Care,' in a media roundtable held recently at a private hospital in Petaling Jaya, Selangor.
